The process of memorizing is critical to human life as we collect experiences in everything we do and we use them in our daily life, as an imitation game. Unfortunately, a large number of people suffer from memory diseases, such as Alzheimer’s disease. Alzheimer is the most common type of dementia and has no cure so far, aggravating continuously until death. The disease causes the victim to lose memories and gradually prevents him or her from performing daily activities without help. Around five million Americans are suffering from it, and it kills about one out of three seniors, which makes it the sixth leading cause of death.

One of the key factors in Alzheimer’s disease is the existence of beta-amyloid proteins in the patient. Though there are a good number of traditional medicines such as Donepezil and Tacrine, researches have shown that cannabis can outperform all of them in preventing or delaying the onset of Alzheimer’s and slow the disease’s progression. The psychoactive compound in cannabis, tetrahydrocannabinol (THC), slows beta-amyloid production and thereby the disease itself when applied in the right dose. A report published in Molecular Pharmaceutics in 2006 theorized that cannabinoids might be shedding the amyloid plaque from affected neurons.

It concluded: “Compared to currently approved drugs prescribed for the treatment of Alzheimer’s disease, THC is a considerably superior inhibitor of [amyloid beta] aggregation.” This finding was supported by 2013, 2014 and 2016 study gradually conducted the Roskamp Institute, University of Florida and the Salk Institute.

A 2006 study revealed that THC stimulated appetite and reduced nighttime agitation, providing relief for Alzheimer’s patients. Another study from the Journal of Alzheimer’s Disease reported that cannabis extract does reduce the negative symptoms of Alzheimer, including: Anxiety,  Depression, Aggression, Insomnia, Hallucinations. Based on the researches done so far, it seems clear that both THC and CBD exerts positive effects on Alzheimer’s patients. Finally, Alzheimer is a qualifying illness for a medical cannabis license in California State, and patients can restraint the development of harmful beta-amyloid proteins in their body using medical cannabis.

You can find out more information in the video below, by Online Medical Card